Enanta Pharmaceuticals
ENTA
$12.07
Share price
-6.00%
Change (1 day)
-49.96%
Change (1 year)
Categories
Enanta Pharmaceuticals (ENTA) - Total assets
Total assets on the balance sheet as of March 2024 : $0.41 B
According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are $0.41 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-09-30 | $0.46 B | 23.14% |
| 2022-09-30 | $0.37 B | -14.44% |
| 2021-09-30 | $0.43 B | -9.74% |
| 2020-09-30 | $0.48 B | -0.75% |
| 2019-09-30 | $0.48 B | 18.25% |
| 2018-09-30 | $0.41 B | 26.82% |
| 2017-09-30 | $0.32 B | 16.13% |
| 2016-09-30 | $0.28 B | 14.33% |
| 2015-09-30 | $0.24 B | 58.29% |
| 2014-09-30 | $0.15 B | 32.86% |
| 2013-09-30 | $0.11 B | 124.25% |
| 2012-09-30 | $52.16 M | 99.89% |
| 2011-09-30 | $26.09 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 41,482.18% | 🇺🇸 USA |
 Novartis NVS | $94.33 B | 22,710.40% | 🇨🇭 Switzerland |
 AbbVie ABBV | $148.87 B | 35,898.42% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $23.91 B | 5,683.34% | 🇺🇸 USA |
 Merck MRK | $105.84 B | 25,494.78% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 23,846.15% | 🇺🇸 USA |